triiodothyronine has been researched along with Recrudescence in 125 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Based on findings that thyroxine may have a beneficial effect on the recurrence of Graves' hyperthyroidism, we prospectively studied the effects of a TSH suppressive treatment with thyroxine on the course of Graves' disease in fifty patients with recent onset of hyperthyroidism." | 9.08 | Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume. ( Pfeilschifter, J; Ziegler, R, 1997) |
| "We examined the chronic electrophysiologic, systemic, and pharmacologic effects of chronic oral amiodarone therapy in 24 patients with refractory ventricular tachycardia and organic heart disease." | 9.05 | Chronic effects of amiodarone in patients with refractory ventricular tachycardia. ( Cappello, G; Rothbart, ST; Saksena, S, 1983) |
| "The possibility of using weekly single doses of 1 mg l-thyroxine for treatment of euthyroid goiters and for prophylaxis against recurrence after thyroidectomies was studied in a series of 37 patients." | 7.65 | [Single weekly doses of 1 mg 1-thyroxine for the treatment of mild goiter and for the prevention of recurrence after goiter surgery]. ( Bauhofer, G; Hugl, H; Riccabona, G; Zechmann, W, 1976) |
| "Concomitantly, no predictor of recurrence of disease could be identified, irrespective of treatment modality." | 6.69 | Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine. ( Kmen, E; Raber, W; Vierhapper, H; Waldhäusl, W, 2000) |
| "Sixty patients with Graves' disease (GD) hyperthyroidism were distributed in two randomized groups." | 6.68 | Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism? ( Foz, M; Granada, ML; Lucas, A; Pizarro, E; Rius, F; Salinas, I; Sanmartí, A, 1997) |
| "A total of 330 Graves' disease patients were treated with methimazole for 1 year." | 6.68 | Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. ( Hayaki, I; Kawai, K; Komaki, G; Kuma, K; Kumagai, LF; Matsubayashi, S; Nagataki, S; Tamai, H, 1995) |
| "303 patients with non-toxic goitre (aged 14-85 years) were studied to determine the extent to which the level of thyroid-hormone dosage until a negative TRH test is reached can be defined in terms of age, body surface area and goitre size." | 5.27 | [Determination of the optimal L-thyroxine dosage for treating nontoxic goiter]. ( Albrecht, W; Biersack, HJ; Oehr, P; Rasche, A; Winkler, C, 1983) |
| "Triiodothyronine (T3)-predominant Graves' disease is characterized by persistently high serum T3 level, normal serum thyroxine (T4) level, and high (greater than 20) serum T3/T4 ratio (nanograms/micrograms) during thionamide drug therapy." | 5.27 | Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease. ( Hershman, JM; Kobayashi, A; Kuma, K; Matsuzuka, F; Mozai, T; Sugawara, M; Takamatsu, J, 1984) |
| "Based on findings that thyroxine may have a beneficial effect on the recurrence of Graves' hyperthyroidism, we prospectively studied the effects of a TSH suppressive treatment with thyroxine on the course of Graves' disease in fifty patients with recent onset of hyperthyroidism." | 5.08 | Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume. ( Pfeilschifter, J; Ziegler, R, 1997) |
| "We examined the chronic electrophysiologic, systemic, and pharmacologic effects of chronic oral amiodarone therapy in 24 patients with refractory ventricular tachycardia and organic heart disease." | 5.05 | Chronic effects of amiodarone in patients with refractory ventricular tachycardia. ( Cappello, G; Rothbart, ST; Saksena, S, 1983) |
| "" If eradication of thyroid hormone excess suffices for the label "cure," then all patients can be cured because total thyroidectomy or high doses of ¹³¹I will abolish hyperthyroidism albeit at the expense of creating another disease (hypothyroidism) requiring lifelong medication with levothyroxine." | 5.01 | Graves' Disease: Can It Be Cured? ( Wiersinga, WM, 2019) |
| "The authors used a Cox regression survival analysis to evaluate the relationship between life course of depressive illness and basal levels of thyroid hormones (triiodothyronine [T(3)], thyroxine [T(4)], and thyrotropin) in 75 outpatients with unipolar major depressive disorder." | 3.70 | Thyroid hormone levels and recurrence of major depression. ( Joffe, RT; Marriott, M, 2000) |
| " Three groups of patients were prospectively evaluated: Group I: 15 patients with Wegener's granulomatosis and 4 patients with severe scleritis received a single dose cyclophosphamide (15 mg/kg bw/day) and 250 mg prednisone i." | 3.70 | Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide). ( Jockenhövel, F; Kummer, G; Mann, K; Philipp, T; Reinhardt, W; Reinwein, D; Sauter, V; Uppenkamp, M; Witzke, O, 1999) |
| "Serum concentrations of thyrotropine (TSH), thyroxine (T4), free T4 (fT4), triiodothyronine (T3) and reverse T3 (rT3) were measured 4 x during a 12-month period in 28 patients with major depressive disorder maintained on lithium prophylaxis for 4-23 years (mean = 11." | 3.69 | The hypothalamic-pituitary-thyroid axis in patients maintained on lithium prophylaxis for years: high triiodothyronine serum concentrations are correlated to the prophylactic efficacy. ( Baumgartner, A; Gräf, KJ; Kürten, I; Müller-Oerlinghausen, B; von Stuckrad, M, 1995) |
| "The serum levels of thyroxine and triiodothyronine (T4 and T3) were investigated at 10 different time points during a 24 h period in 31 inpatients meeting the RDC criteria for acute major depressive disorder." | 3.67 | Twenty-four-hour serum levels of T4 and T3 in relation to decreased TSH serum levels and decreased TSH response to TRH in affective disorders. ( Beck-Friis, J; Kjellman, BF; Ljunggren, JG; Undén, F; Wetterberg, L, 1986) |
| "The possibility of using weekly single doses of 1 mg l-thyroxine for treatment of euthyroid goiters and for prophylaxis against recurrence after thyroidectomies was studied in a series of 37 patients." | 3.65 | [Single weekly doses of 1 mg 1-thyroxine for the treatment of mild goiter and for the prevention of recurrence after goiter surgery]. ( Bauhofer, G; Hugl, H; Riccabona, G; Zechmann, W, 1976) |
| "Further, the relapse and recurrence rates within 3 months after respective treatments were also measured." | 2.78 | Efficacy of repetitive transcranial magnetic stimulation in the treatment of patients with chronic primary insomnia. ( Gao, D; Jiang, CG; Yi, ML; Yue, FG; Zhang, T, 2013) |
| "To study the role of T4 and T3 on the recurrence rate of Graves' disease 108 patients with Graves' disease (22 males, age: 49." | 2.71 | T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy. ( Doufas, AG; Koutras, DA; Mantzos, E; Mantzos, J; Mastorakos, G, 2003) |
| "Concomitantly, no predictor of recurrence of disease could be identified, irrespective of treatment modality." | 2.69 | Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine. ( Kmen, E; Raber, W; Vierhapper, H; Waldhäusl, W, 2000) |
| "There was no difference between the recurrence rates in the two groups, despite the fact that serum thyrotropin concentrations were undetectable in 73 percent of patients in the carbimazole-T4 group on at least 75 percent of their visits." | 2.68 | Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. ( Beckett, G; Gold, A; McIver, B; Rae, P; Toft, A; Wilkinson, E, 1996) |
| "A total of 330 Graves' disease patients were treated with methimazole for 1 year." | 2.68 | Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients. ( Hayaki, I; Kawai, K; Komaki, G; Kuma, K; Kumagai, LF; Matsubayashi, S; Nagataki, S; Tamai, H, 1995) |
| "Sixty patients with Graves' disease (GD) hyperthyroidism were distributed in two randomized groups." | 2.68 | Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism? ( Foz, M; Granada, ML; Lucas, A; Pizarro, E; Rius, F; Salinas, I; Sanmartí, A, 1997) |
| " The authors report on the lack of efficacy of adjunctive L-triiodothyronine (T3; 25 micrograms/day) in a sample of 20 outpatient unipolar depressives who had not responded to greater than or equal to 12 weeks of treatment with imipramine (mean dosage = 240 mg/day) and interpersonal psychotherapy." | 2.66 | Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine. ( Jarrett, DB; Kupfer, DJ; Thase, ME, 1989) |
| "Twenty patients with benign thyroid cysts were studied in a prospective double-blind fashion to determine the effect of thyroid therapy on the recurrence of these cysts after aspiration." | 2.65 | The role of thyroid therapy in patients with thyroid cysts. ( Fariss, BL; McCowen, KD; Reed, JW, 1980) |
| " In patients with a high TSH despite being clinically euthyroid, the use of thyroid extract in low dosage (50 mg/day) would appear to be desirable in avoiding the subsequent development of hypothyroidism." | 2.64 | [Biological changes in 88 cases of Basedow's disease treated by radioactive iodine]. ( Brunelle, P; Courtois, H; Nouel, JP; Poirier, A; Schrub, JC; Segond, G, 1976) |
| "Autoimmune reactions in Graves' disease (GD) occur not only in the thyroid gland, but also in the orbital connective tissue, eyelids, extraocular muscles." | 1.56 | Radioiodine therapy and Graves' disease - Myths and reality. ( Borowska, M; Czarnywojtek, A; Gut, P; Karlińska, M; Kobylecka, M; Krolicki, L; Plazinska, MT; Prasek, K; Ruchala, M; Sawicka-Gutaj, N; Wolinski, K; Zgorzalewicz-Stachowiak, M, 2020) |
| "Relapse was most common during the first year, and prognosis was excellent after 4 years without relapse." | 1.40 | Long-term prognosis after medical treatment of Graves' disease in a northern Swedish population 2000-2010. ( Eliasson, M; Filipsson Nyström, H; Mohlin, E, 2014) |
| "Exogenous thyrotoxicosis is usually caused by ingestion of excessive amounts of thyroid hormone, which could be intentional or surreptitious (known as factitious thyrotoxicosis)." | 1.38 | Intermittent and recurrent episodes of subclinical hypothyroidism, central hypothyroidism and T3-toxicosis in an elderly woman. ( Díez, JJ; Iglesias, P; Megías, MC; Villanueva, MG, 2012) |
| "Painless thyroiditis is characterized by transient thyrotoxicosis with complete recovery." | 1.35 | Clinical characteristics of frequently recurring painless thyroiditis: contributions of higher thyroid hormone levels, younger onset, male gender, presence of thyroid autoantibody and absence of goiter to repeated recurrence. ( Isozaki, O; Nishimaki, M; Okubo, Y; Takano, K; Yoshihara, A, 2009) |
| "Cataract surgery may lead to recrudescence of TAO in predisposed individuals." | 1.35 | Reactivation of thyroid-associated orbitopathy after cataract surgery. ( Douglas, RS; Goldberg, RA; Menghani, RM; Shadpour, JM; Tsirbas, A, 2009) |
| "When carbimazole was stopped, right GM recurred together with hyperthyroidism." | 1.33 | Recurrent painful unilateral gynaecomastia-interactions between hyperthyroidism and hypogonadism. ( Davies, DP; Jayapaul, M; Large, DM; Williams, MR, 2006) |
| "Forty-five patients were treated for active hyperthyroidism, 161 were euthyroid (85 immediately before withdrawal of antithyroid drug at maintenance doses, 76 in stable remission after withdrawal of antithyroid treatment)." | 1.33 | Relationship between the sonographic appearance of the thyroid and the clinical course and autoimmune activity of Graves' disease. ( Baldini, M; Bonfanti, MT; Cantalamessa, L; Castagnone, D; Orsatti, A, 2005) |
| "Retrospective study on serum samples of Graves' disease patients treated by antithyroid drugs for 18 months." | 1.31 | Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay. ( Massart, C; Maugendre, D, 2001) |
| "Among 14 T4-treated patients, recurrence of hypothyroidism occurred in 7 patients after treatment was discontinued." | 1.31 | Side-effects of iodized oil administration in patients with simple goiter. ( Azizi, F; Daftarian, N, 2001) |
| " The beginning of therapy, dosage of drugs, length of application and results of treatment are critically evaluated, with special emphasis on the rate and time of remission, on the frequency of recurrences and on the success of additional treatments such as surgery and/or radioiodine application." | 1.31 | [Graves' disease. Clinical features and treatment results]. ( Amor, H; Crivellaro, C; Leimgruber, K; Oberhofer, R, 2001) |
| "However, in predicting the recurrence of thyrotoxicosis after discontinuing ATD it has been of little value." | 1.31 | Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease. ( Feldt-Rasmussen, U; Nygaard, B; Rasmussen, AK; Zimmermann-Belsing, T, 2002) |
| "Both exacerbations and recurrences of GH appeared primarily within 4-6 months after delivery." | 1.31 | Postpartum recurrence of Graves' hyperthyroidism can be prevented by the continuation of antithyroid drugs during pregnancy. ( Hoshikawa, S; Ito, S; Mori, K; Nakagawa, Y; Yamamoto, M; Yoshida, K, 2002) |
| "Aged patients with hyperthyroid Graves' disease show a more favorable response to antithyroid drugs than young counterparts." | 1.29 | Age-related therapeutic response to antithyroid drug in patients with hyperthyroid Graves' disease. ( Aizawa, T; Hashizume, K; Ichikawa, K; Koizumi, Y; Komiya, I; Yamada, T, 1994) |
| "The sCD4 level in the Graves' disease group was not different from control values and did not change significantly with treatment." | 1.29 | Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease. ( Balázs, C; Bokk, A; Farid, NR, 1994) |
| "Eighty-five patients with Graves' disease in clinical remission after treatment for over 1 year by methimazole therapy (36 patients, group A) or subtotal thyroidectomy (49 patients, group B) who became undetectable for serum thyrotropin levels (TSH less than 0." | 1.28 | A follow-up study of 85 patients with Graves' disease in remission who developed undetectable serum thyroid-stimulating hormone concentrations using sensitive TSH assays. ( Kuma, K; Matsubayashi, S; Morita, T; Mukuta, T; Nagai, K; Nakagawa, T; Tamai, H, 1991) |
| "One hundred and twelve new cases of Graves' disease were treated by tapazole for 6 months and followed up for another 12 months." | 1.28 | [Evaluation of a logistic regression model in predicting the prognosis of Graves' disease treated by antithyroid drugs]. ( Cheng, Y; Li, J; Liang, Z; Pan, X; Wei, S; Xu, S, 1991) |
| "Eighty-three patients with Graves' disease had been treated with methylmercaptoimidazole (MMI)." | 1.28 | Studies on the T3 suppression test with reference to the thyroidal 123I uptake in Graves' disease: comparison of 24-hour and 3-hour uptake. ( Inukai, T; Iwashita, A; Kobayashi, I; Kobayashi, S; Ohshima, K; Shimomura, Y; Yamaguchi, T; Yamaguchi, Y, 1990) |
| "One hundred and twelve new cases with Graves' disease were treated by tapazole for 6 months and followed-up for another 12 months in a prospective study." | 1.28 | [Observation of the outcome of 112 cases with Graves' disease treated by short-term antithyroid drug therapy for one year]. ( Cheng, Y; Li, J; Liang, Z; Wang, Q; Wei, S; Xian, L, 1990) |
| "Triiodothyronine (T3)-predominant Graves' disease is characterized by persistently high serum T3 level, normal serum thyroxine (T4) level, and high (greater than 20) serum T3/T4 ratio (nanograms/micrograms) during thionamide drug therapy." | 1.27 | Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease. ( Hershman, JM; Kobayashi, A; Kuma, K; Matsuzuka, F; Mozai, T; Sugawara, M; Takamatsu, J, 1984) |
| "303 patients with non-toxic goitre (aged 14-85 years) were studied to determine the extent to which the level of thyroid-hormone dosage until a negative TRH test is reached can be defined in terms of age, body surface area and goitre size." | 1.27 | [Determination of the optimal L-thyroxine dosage for treating nontoxic goiter]. ( Albrecht, W; Biersack, HJ; Oehr, P; Rasche, A; Winkler, C, 1983) |
| "We saw a total of 4 episodes of the recurrence of subacute thyroiditis in 3 patients out of 222." | 1.27 | Recurrence of subacute thyroiditis over 10 years after the first attack in three cases. ( Fukazawa, H; Itagaki, Y; Kaise, K; Kaise, N; Kudo, Y; Saito, S; Sakurada, T; Tamura, M; Yamamoto, M; Yoshida, K, 1988) |
| "Twenty-three (12." | 1.27 | Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission. ( Aizawa, T; Kamoi, K; Koizumi, Y; Murakami, M; Takahashi, Y; Watanabe, T; Yamada, T, 1988) |
| "Of the 31 recurrences, 14 had not been treated at the time of follow-up." | 1.26 | Nontoxic goitre. II. A study of the pituitary-thyroid axis in 14 recurrent cases. ( Geerdsen, JP; Hee, P, 1982) |
| "When amiodarone was stopped in nine patients, the changes in QTc, T4 and rT3 regressed toward normal and arrhythmia recurred in eight 2-20 weeks (mean 7." | 1.26 | Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy. ( Hendrickson, JA; Hershman, J; Melmed, S; Nademanee, K; Reed, AW; Singh, BN, 1982) |
| " It is suggested therefore that the long term administration of antithryoid drugs can be a useful treatment for intractable cases." | 1.26 | Long term antithyroid drug therapy for intractable cases of Graves' disease. ( Shizume, K, 1978) |
| "We suggest that the transient recurrence of hyperthyroidism in Graves' disease may be induced by immunological changes after delivery." | 1.26 | Transient recurrence of hyperthyroidism after delivery in Graves' disease. ( Amino, N; Kuro, R; Miyai, K; Tanaka, F; Yamamoto, T, 1977) |
| "The incidence and features of goitre recurrences were investigated in a sample population of patients operated at the University of Turin Endocrine Surgery Centre." | 1.26 | [Clinical and hormonal evaluation of recurrence of goiter after thyroidectomy]. ( Abeatici, S; Palestini, N; Sigismondi, S, 1979) |
| "Hyperthyroidism was diagnosed clinically after elevated serum T3 concentrations in 11 patients and at the same time in 2 patients." | 1.25 | Hormonal pattern of relapse in hyperthyroidism. ( Acosta, M; Chalkley, S; Howorth, PJ; Leatherdale, B; Marsden, P; McKerron, CG, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 65 (52.00) | 18.7374 |
| 1990's | 25 (20.00) | 18.2507 |
| 2000's | 20 (16.00) | 29.6817 |
| 2010's | 14 (11.20) | 24.3611 |
| 2020's | 1 (0.80) | 2.80 |
| Authors | Studies |
|---|---|
| Plazinska, MT | 1 |
| Sawicka-Gutaj, N | 1 |
| Czarnywojtek, A | 1 |
| Wolinski, K | 1 |
| Kobylecka, M | 1 |
| Karlińska, M | 1 |
| Prasek, K | 1 |
| Zgorzalewicz-Stachowiak, M | 1 |
| Borowska, M | 1 |
| Gut, P | 1 |
| Ruchala, M | 1 |
| Krolicki, L | 1 |
| Hashimoto, K | 1 |
| Nishihara, E | 1 |
| Matsumoto, M | 2 |
| Matsumoto, S | 1 |
| Nakajima, Y | 1 |
| Tsujimoto, K | 1 |
| Yamakage, H | 1 |
| Satoh-Asahara, N | 1 |
| Noh, JY | 2 |
| Ito, K | 2 |
| Miyauchi, A | 1 |
| Mori, M | 1 |
| Yamada, M | 1 |
| Ogawa, Y | 1 |
| Wei, SB | 1 |
| Wang, W | 1 |
| Liu, N | 1 |
| Chen, J | 1 |
| Guo, XY | 1 |
| Tang, RB | 1 |
| Yu, RH | 1 |
| Long, DY | 1 |
| Sang, CH | 1 |
| Jiang, CX | 1 |
| Li, SN | 1 |
| Wen, SN | 1 |
| Wu, JH | 1 |
| Bai, R | 1 |
| Du, X | 1 |
| Dong, JZ | 1 |
| Ma, CS | 1 |
| Wiersinga, WM | 2 |
| Jiang, CG | 1 |
| Zhang, T | 1 |
| Yue, FG | 1 |
| Yi, ML | 1 |
| Gao, D | 1 |
| Mohlin, E | 1 |
| Filipsson Nyström, H | 1 |
| Eliasson, M | 1 |
| Yoshihara, A | 2 |
| Mukasa, K | 1 |
| Suzuki, M | 1 |
| Ohye, H | 1 |
| Kunii, Y | 1 |
| Watanabe, N | 1 |
| Suzuki, N | 1 |
| Kameda, T | 1 |
| Sugino, K | 1 |
| Sharma, S | 1 |
| Dabla, PK | 1 |
| Kumar, M | 1 |
| Liu, X | 1 |
| Shi, B | 1 |
| Li, H | 1 |
| Yang, X | 1 |
| Sun, G | 1 |
| Wei, J | 1 |
| Huang, B | 1 |
| Zhao, L | 1 |
| Wang, Y | 1 |
| Zhou, B | 1 |
| Tao, L | 1 |
| Ma, X | 1 |
| Tun, NN | 1 |
| Beckett, G | 2 |
| Zammitt, NN | 1 |
| Strachan, MW | 1 |
| Seckl, JR | 1 |
| Gibb, FW | 1 |
| Kim, YA | 1 |
| Cho, SW | 1 |
| Choi, HS | 1 |
| Moon, S | 1 |
| Moon, JH | 1 |
| Kim, KW | 1 |
| Park, DJ | 1 |
| Yi, KH | 1 |
| Park, YJ | 1 |
| Cho, BY | 1 |
| Miao, J | 1 |
| Zhao, YJ | 1 |
| Wang, S | 1 |
| Jiang, XH | 1 |
| Zhao, ZF | 1 |
| Gu, LQ | 1 |
| Gu, XJ | 1 |
| Ning, G | 1 |
| Shadpour, JM | 1 |
| Menghani, RM | 1 |
| Douglas, RS | 1 |
| Goldberg, RA | 1 |
| Tsirbas, A | 1 |
| Nishimaki, M | 1 |
| Isozaki, O | 1 |
| Okubo, Y | 1 |
| Takano, K | 1 |
| Balázs, C | 2 |
| Türke, B | 1 |
| Vámos, A | 1 |
| Megías, MC | 1 |
| Iglesias, P | 1 |
| Villanueva, MG | 1 |
| Díez, JJ | 1 |
| Wolters, B | 1 |
| Lass, N | 1 |
| Reinehr, T | 1 |
| Nakagawa, Y | 1 |
| Mori, K | 1 |
| Hoshikawa, S | 1 |
| Yamamoto, M | 3 |
| Ito, S | 1 |
| Yoshida, K | 2 |
| Custro, N | 1 |
| Ganci, A | 1 |
| Scafidi, V | 1 |
| CORBUS, HF | 1 |
| Stalenheim, EG | 1 |
| Mastorakos, G | 1 |
| Doufas, AG | 1 |
| Mantzos, E | 1 |
| Mantzos, J | 1 |
| Koutras, DA | 1 |
| Navaneethakrishnan, R | 1 |
| Lindow, SW | 1 |
| Masson, EA | 1 |
| Allan, B | 1 |
| Baldini, M | 2 |
| Orsatti, A | 1 |
| Bonfanti, MT | 1 |
| Castagnone, D | 2 |
| Cantalamessa, L | 2 |
| Ueda, M | 1 |
| Inaba, M | 1 |
| Kumeda, Y | 1 |
| Nagasaki, T | 1 |
| Hiura, Y | 1 |
| Tahara, H | 1 |
| Onoda, N | 1 |
| Ishikawa, T | 1 |
| Nishizawa, Y | 1 |
| Jayapaul, M | 1 |
| Williams, MR | 1 |
| Davies, DP | 1 |
| Large, DM | 1 |
| Tagami, T | 1 |
| Hagiwara, H | 1 |
| Kimura, T | 1 |
| Usui, T | 1 |
| Shimatsu, A | 1 |
| Naruse, M | 1 |
| Mittra, ES | 1 |
| McDougall, IR | 1 |
| Smeulers, J | 1 |
| Docter, R | 1 |
| Visser, TJ | 1 |
| Hennemann, G | 1 |
| Takamatsu, J | 2 |
| Saksena, S | 1 |
| Rothbart, ST | 1 |
| Cappello, G | 1 |
| Biersack, HJ | 1 |
| Albrecht, W | 1 |
| Oehr, P | 1 |
| Rasche, A | 1 |
| Winkler, C | 1 |
| Benvenga, S | 1 |
| Granata, A | 1 |
| Trimarchi, F | 1 |
| Sugawara, M | 1 |
| Kuma, K | 4 |
| Kobayashi, A | 1 |
| Matsuzuka, F | 2 |
| Mozai, T | 1 |
| Hershman, JM | 1 |
| Blackshear, JL | 1 |
| Schultz, AL | 1 |
| Napier, JS | 1 |
| Stuart, DD | 1 |
| Totsuka, Y | 1 |
| Kojima, I | 1 |
| Yamashita, N | 1 |
| Togawa, K | 1 |
| Sawaki, N | 1 |
| Ogata, E | 1 |
| Weber, MJ | 1 |
| Hefti, E | 1 |
| Wetz, B | 1 |
| Kinser, J | 1 |
| Tamai, H | 3 |
| Nakagawa, T | 2 |
| Fukino, O | 1 |
| Ohsako, N | 1 |
| Shinzato, R | 1 |
| Suematsu, H | 1 |
| Nagataki, S | 2 |
| Taylor, HC | 1 |
| Sheeler, LR | 1 |
| Nademanee, K | 1 |
| Singh, BN | 1 |
| Hendrickson, JA | 1 |
| Reed, AW | 1 |
| Melmed, S | 1 |
| Hershman, J | 1 |
| Geerdsen, JP | 1 |
| Hee, P | 1 |
| Lindstedt, G | 1 |
| Lundberg, PA | 1 |
| Sjögren, B | 1 |
| Ernest, I | 1 |
| Sundquist, O | 1 |
| McCowen, KD | 1 |
| Reed, JW | 1 |
| Fariss, BL | 1 |
| Baumgartner, A | 1 |
| von Stuckrad, M | 1 |
| Müller-Oerlinghausen, B | 1 |
| Gräf, KJ | 1 |
| Kürten, I | 1 |
| Takasu, N | 1 |
| Akamine, H | 1 |
| Komiya, I | 2 |
| Yamada, T | 3 |
| Hayaki, I | 1 |
| Kawai, K | 1 |
| Komaki, G | 1 |
| Matsubayashi, S | 2 |
| Kumagai, LF | 1 |
| Tajiri, J | 1 |
| Noguchi, S | 2 |
| Morita, M | 1 |
| Tamaru, M | 1 |
| Murakami, T | 2 |
| Murakami, N | 1 |
| Brechignac, X | 1 |
| Broussolle, C | 1 |
| Nove-Josserand, R | 1 |
| Vital-Durand, D | 1 |
| Orgiazzi, J | 1 |
| Levrat, R | 1 |
| Dons, RF | 1 |
| Shakir, KM | 1 |
| Borisova, NK | 1 |
| Ametov, AS | 1 |
| Khachatrian, EI | 1 |
| Daurov, BI | 1 |
| Bondarenko, VO | 1 |
| Bokk, A | 1 |
| Farid, NR | 1 |
| Aizawa, T | 2 |
| Koizumi, Y | 2 |
| Ichikawa, K | 1 |
| Hashizume, K | 1 |
| McIver, B | 1 |
| Rae, P | 1 |
| Wilkinson, E | 1 |
| Gold, A | 1 |
| Toft, A | 1 |
| Pfeilschifter, J | 1 |
| Ziegler, R | 1 |
| Lucas, A | 1 |
| Salinas, I | 1 |
| Rius, F | 1 |
| Pizarro, E | 1 |
| Granada, ML | 1 |
| Foz, M | 1 |
| Sanmartí, A | 1 |
| Joffe, RT | 2 |
| Rivolta, R | 1 |
| Meroni, L | 1 |
| Pappalettera, M | 1 |
| Escobar Jiménez, F | 1 |
| Luna López, V | 1 |
| Fernández Soto, ML | 1 |
| Quezada Charneco, M | 1 |
| Glinoer, D | 1 |
| Reinhardt, W | 1 |
| Sauter, V | 1 |
| Jockenhövel, F | 1 |
| Kummer, G | 1 |
| Uppenkamp, M | 1 |
| Witzke, O | 1 |
| Philipp, T | 1 |
| Reinwein, D | 2 |
| Mann, K | 1 |
| Sonnet, E | 1 |
| Massart, C | 2 |
| Gibassier, J | 1 |
| Allannic, H | 1 |
| Maugendre, D | 2 |
| Raber, W | 1 |
| Kmen, E | 1 |
| Waldhäusl, W | 1 |
| Vierhapper, H | 1 |
| Marriott, M | 1 |
| Azizi, F | 1 |
| Daftarian, N | 1 |
| Mizukoshi, T | 1 |
| Futata, T | 1 |
| Yamashita, H | 1 |
| Crivellaro, C | 1 |
| Oberhofer, R | 1 |
| Leimgruber, K | 1 |
| Amor, H | 1 |
| Zimmermann-Belsing, T | 1 |
| Nygaard, B | 1 |
| Rasmussen, AK | 1 |
| Feldt-Rasmussen, U | 2 |
| Marsden, P | 1 |
| Chalkley, S | 1 |
| Leatherdale, B | 1 |
| Howorth, PJ | 1 |
| Acosta, M | 1 |
| McKerron, CG | 1 |
| Linder, MM | 1 |
| Voigt, HG | 1 |
| Momotani, N | 1 |
| Hamada, N | 1 |
| Ban, Y | 1 |
| Mimura, T | 1 |
| Nishikawa, Y | 1 |
| Shizume, K | 1 |
| Horster, FA | 3 |
| Mitsunaga, M | 1 |
| Hasegawa, K | 1 |
| Nakagawa, O | 1 |
| Nakashima, Y | 1 |
| Miyoshi, M | 1 |
| Suzuki, S | 1 |
| Ofuji, T | 1 |
| Horton, PW | 1 |
| Millar, WT | 1 |
| McLarty, DG | 1 |
| Alexander, WD | 1 |
| Lundström, B | 1 |
| Gillquist, J | 1 |
| Karlberg, B | 1 |
| Kågedal, B | 1 |
| Tegler, L | 1 |
| Abeatici, S | 1 |
| Palestini, N | 1 |
| Sigismondi, S | 1 |
| Keil, I | 1 |
| Wasserroth, R | 1 |
| Amino, N | 1 |
| Miyai, K | 1 |
| Yamamoto, T | 1 |
| Kuro, R | 1 |
| Tanaka, F | 1 |
| Scazziga, BR | 1 |
| Abe, K | 1 |
| Taguchi, T | 1 |
| Okuno, A | 1 |
| Matsuura, N | 1 |
| Takebayashi, K | 1 |
| Sasaki, H | 1 |
| Koch, G | 1 |
| de Heer, K | 1 |
| Rauchenberger, B | 1 |
| Wahl, R | 1 |
| Hornstein, C | 1 |
| Grussendorf, M | 1 |
| Meybier, H | 1 |
| Hüfner, M | 1 |
| Röher, HD | 1 |
| Schrub, JC | 1 |
| Nouel, JP | 1 |
| Brunelle, P | 1 |
| Segond, G | 1 |
| Courtois, H | 1 |
| Poirier, A | 1 |
| Gemsenjäger, E | 1 |
| Staub, JJ | 1 |
| Girard, J | 1 |
| Heitz, P | 1 |
| Bauhofer, G | 1 |
| Hugl, H | 1 |
| Zechmann, W | 1 |
| Riccabona, G | 2 |
| Blichert-Toft, M | 2 |
| Jorgensen, SJ | 1 |
| Hansen, JB | 1 |
| Watt-Boolsen, S | 1 |
| Christiansen, C | 1 |
| Ibsen, J | 1 |
| Martino, E | 1 |
| Balzano, S | 1 |
| Bartalena, L | 1 |
| Loviselli, A | 1 |
| Sica, V | 1 |
| Petrini, L | 1 |
| Grasso, L | 1 |
| Piga, M | 1 |
| Braverman, LE | 1 |
| Schifferdecker, E | 1 |
| Wei, S | 2 |
| Pan, X | 1 |
| Liang, Z | 2 |
| Xu, S | 1 |
| Cheng, Y | 2 |
| Li, J | 2 |
| Nagai, K | 1 |
| Mukuta, T | 1 |
| Morita, T | 1 |
| Berghout, A | 1 |
| Drexhage, HA | 1 |
| Smits, NJ | 1 |
| Touber, JL | 1 |
| Yamaguchi, T | 1 |
| Kobayashi, I | 1 |
| Yamaguchi, Y | 1 |
| Iwashita, A | 1 |
| Inukai, T | 1 |
| Ohshima, K | 1 |
| Shimomura, Y | 1 |
| Kobayashi, S | 1 |
| Langer, HJ | 1 |
| Leicht, E | 1 |
| Koch, B | 1 |
| Weinheimer, B | 1 |
| Berberich, R | 1 |
| Strohfeldt, P | 1 |
| Weinges, KF | 1 |
| Xian, L | 1 |
| Wang, Q | 1 |
| Kasagi, K | 1 |
| Iida, Y | 1 |
| Hatabu, H | 1 |
| Tokuda, Y | 1 |
| Arai, K | 1 |
| Endo, K | 1 |
| Konishi, J | 1 |
| Gillette, GM | 1 |
| Garbutt, JC | 1 |
| Quade, DE | 1 |
| Wilson, R | 1 |
| Fraser, WD | 1 |
| McKillop, JH | 1 |
| Thomson, JA | 1 |
| Thase, ME | 1 |
| Kupfer, DJ | 1 |
| Jarrett, DB | 1 |
| Eshøj, O | 1 |
| Kvetny, J | 1 |
| Mogensen, EF | 1 |
| Bech, K | 1 |
| Bliddal, H | 1 |
| Undén, F | 1 |
| Ljunggren, JG | 1 |
| Kjellman, BF | 1 |
| Beck-Friis, J | 1 |
| Wetterberg, L | 1 |
| Date, J | 1 |
| Haas, V | 1 |
| Hegedüs, L | 1 |
| Hansen, JM | 1 |
| Veiergang, D | 1 |
| Karstrup, S | 1 |
| Murakami, M | 1 |
| Takahashi, Y | 1 |
| Watanabe, T | 1 |
| Kamoi, K | 1 |
| Lipworth, BJ | 1 |
| Dhillon, DP | 1 |
| Clark, RA | 1 |
| Newton, RW | 1 |
| Saito, S | 1 |
| Sakurada, T | 1 |
| Tamura, M | 1 |
| Kudo, Y | 1 |
| Kaise, K | 1 |
| Kaise, N | 1 |
| Fukazawa, H | 1 |
| Itagaki, Y | 1 |
| Ikenoue, H | 1 |
| Okamura, K | 1 |
| Kuroda, T | 1 |
| Sato, K | 1 |
| Yoshinari, M | 1 |
| Fujishima, M | 1 |
| Rippere, V | 1 |
| Jacobs, HS | 1 |
| Mackie, DB | 1 |
| Eastman, CJ | 1 |
| Ellis, SM | 1 |
| Ekins, RP | 1 |
| McHardy-Young, S | 1 |
| Wilson, WW | 1 |
| Gordin, A | 1 |
| Hackenberg, K | 1 |
| Schemmel, K | 1 |
| Pickardt, CR | 1 |
| Erhardt, F | 1 |
| Horn, K | 1 |
| Lehnert, P | 1 |
| Schriba, PC | 1 |
| Wildmeister, W | 2 |
| Rainer, O | 1 |
| Klappacher, G | 1 |
| Gasiorowski, W | 1 |
| Shenkman, L | 2 |
| Mitsuma, T | 2 |
| Blum, M | 1 |
| Hollander, CS | 2 |
| Lande, G | 1 |
| Kjolseth, I | 1 |
| MacGillivray, MH | 1 |
| Crawford, JD | 1 |
| Robey, JS | 1 |
| Owens, R | 1 |
| Reiter, E | 1 |
| Scholz, K | 1 |
| Bauer, H | 1 |
| Hedley, AJ | 1 |
| Ross, IP | 1 |
| Beck, JS | 1 |
| Donald, D | 1 |
| Albert-Recht, F | 1 |
| Michie, W | 1 |
| Crooks, J | 1 |
| Klug, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| he Efficacy and Safety of Combining Mycophenolate Mofetil With Methimazole on Remission of Newly Diagnosis Graves' Disease (3M-RGD Trial): an Open-label, Randomized Trial[NCT06068179] | Phase 2/Phase 3 | 205 participants (Anticipated) | Interventional | 2023-10-08 | Not yet recruiting | ||
| "Evaluation of the Intervention Program Obeldicks for Obese Children and Adolescents"[NCT00435734] | 4,000 participants (Actual) | Observational | 1999-07-31 | Active, not recruiting | |||
| The Effects of Thyroid Hormone on Cytochrome P450 and P-Glycoprotein Activity in Thyroid Cancer Patients[NCT00080574] | Phase 2 | 20 participants | Interventional | 2004-04-30 | Completed | ||
| Efficiency and Safety Study of Short-term Prednisone to Treat Moderate and Severe Subacute Thyroiditis[NCT01837433] | Phase 4 | 40 participants (Actual) | Interventional | 2013-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for triiodothyronine and Recrudescence
| Article | Year |
|---|---|
Graves' Disease: Can It Be Cured?
Topics: Adult; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Hypot | 2019 |
Refractory depression: treatment strategies, with particular reference to the thyroid axis.
Topics: Depressive Disorder; Drug Resistance; Humans; Recurrence; Thyroid Gland; Triiodothyronine | 1997 |
[Advances in diagnosis and treatment of hypothyroidism].
Topics: Autoantibodies; Autoimmune Diseases; Cholesterol; Dextrothyroxine; Graves Disease; Humans; Hypothyro | 1973 |
18 trials available for triiodothyronine and Recrudescence
| Article | Year |
|---|---|
Efficacy of repetitive transcranial magnetic stimulation in the treatment of patients with chronic primary insomnia.
Topics: Adrenocorticotropic Hormone; Adult; Anti-Anxiety Agents; Chronic Disease; Estazolam; Female; Humans; | 2013 |
TSH and free triiodothyronine concentrations are associated with weight loss in a lifestyle intervention and weight regain afterwards in obese children.
Topics: Adolescent; Body Mass Index; Child; Child Development; Diet, Reducing; Exercise; Female; Follow-Up S | 2013 |
T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantigens; Carbimazole; Female; Graves Disease; Horm | 2003 |
Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Atrioventricular Node; Benzofurans; Clinical Trials a | 1983 |
The role of thyroid therapy in patients with thyroid cysts.
Topics: Adult; Cysts; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Recurrence; Suction; | 1980 |
Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients.
Topics: Adolescent; Adult; Antibodies; Child; Drug Therapy, Combination; Female; Graves Disease; Humans; Mal | 1995 |
Serum sialic acid levels in the diagnosis and follow-up of subacute granulomatous thyroiditis.
Topics: Adult; Aged; C-Reactive Protein; Female; Follow-Up Studies; Humans; Male; Middle Aged; N-Acetylneura | 1993 |
Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
Topics: Adult; Antibodies; Antithyroid Agents; Carbimazole; Drug Therapy, Combination; Female; Graves Diseas | 1996 |
Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volume.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Carbimazole; Female; Graves Disease; Humans; Hypert | 1997 |
Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism?
Topics: Adolescent; Adult; Antithyroid Agents; Autoantibodies; Carbimazole; Child; Female; Graves Disease; H | 1997 |
Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
Topics: Adult; Aged; Antibodies; Antithyroid Agents; Arteries; Female; Graves Disease; Hormones; Humans; Iod | 1997 |
Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Female; Graves Disease; Humans; Immunochemistry; Immunoglobulins, Thyroid-S | 1999 |
Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine.
Topics: Adolescent; Adult; Aged; Antibodies; Antithyroid Agents; Drug Combinations; Female; Goiter; Graves D | 2000 |
[Biological changes in 88 cases of Basedow's disease treated by radioactive iodine].
Topics: Age Factors; Clinical Trials as Topic; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyroi | 1976 |
Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Autoantibodies; Female; Graves Disease; Humans; Immun | 1991 |
Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre.
Topics: Adult; Carbimazole; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fe | 1990 |
Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine.
Topics: Adult; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; | 1989 |
Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size?
Topics: Adolescent; Adult; Aged; Female; Goiter; Humans; Male; Middle Aged; Postoperative Complications; Ran | 1987 |
104 other studies available for triiodothyronine and Recrudescence
| Article | Year |
|---|---|
Radioiodine therapy and Graves' disease - Myths and reality.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cigarette Smoking; Female; Graves Disease; Graves Ophthalmopa | 2020 |
Sialic Acid-Binding Immunoglobulin-Like Lectin1 as a Novel Predictive Biomarker for Relapse in Graves' Disease: A Multicenter Study.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Female; Graves Disease; Humans; Male; Middle Aged; Progn | 2018 |
U-shaped association between serum free triiodothyronine and recurrence of atrial fibrillation after catheter ablation.
Topics: Aged; Atrial Fibrillation; Biomarkers; Catheter Ablation; China; Cohort Studies; Electrocardiography | 2018 |
Long-term prognosis after medical treatment of Graves' disease in a northern Swedish population 2000-2010.
Topics: Adult; Antithyroid Agents; Female; Goiter; Graves Disease; Humans; Kaplan-Meier Estimate; Male; Midd | 2014 |
Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
Topics: Algorithms; Chorionic Gonadotropin; Diagnosis, Differential; Female; Graves Disease; Hashimoto Disea | 2015 |
Evaluation of Thyroid Hormone Status in Children with Steroid Resistant Nephrotic Syndrome: A North India Study.
Topics: Asymptomatic Diseases; Child; Child, Preschool; Creatinine; Cross-Sectional Studies; Disease Progres | 2015 |
Valuable predictive features of relapse of Graves' disease after antithyroid drug treatment.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunog | 2015 |
Comparison of hair thyroid hormones between first-episode and recurrent patients with depression in female Chinese.
Topics: Adolescent; Adult; China; Depressive Disorder, Major; Female; Hair; Humans; Middle Aged; Recurrence; | 2016 |
Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease Relapse.
Topics: Adult; Age Factors; Antithyroid Agents; Autoantibodies; Carbimazole; Female; Graves Disease; Humans; | 2016 |
The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study.
Topics: Adult; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Logistic Models; Male; | 2017 |
[Prognostic factors in the relapse of Graves disease].
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Immu | 2008 |
Reactivation of thyroid-associated orbitopathy after cataract surgery.
Topics: Aged, 80 and over; Cataract Extraction; Female; Graves Ophthalmopathy; Humans; Orbital Diseases; Rec | 2009 |
Clinical characteristics of frequently recurring painless thyroiditis: contributions of higher thyroid hormone levels, younger onset, male gender, presence of thyroid autoantibody and absence of goiter to repeated recurrence.
Topics: Adolescent; Adult; Age of Onset; Autoantibodies; Female; Humans; Male; Middle Aged; Recurrence; Regr | 2009 |
[Determination of serum neopterin levels in patients with autoimmune thyroid diseases].
Topics: Adult; Aged; Autoantibodies; Biomarkers; Female; Graves Disease; Hashimoto Disease; Humans; Iodide P | 2012 |
Intermittent and recurrent episodes of subclinical hypothyroidism, central hypothyroidism and T3-toxicosis in an elderly woman.
Topics: Aged, 80 and over; Animals; Female; Humans; Hypothyroidism; Meat; Recurrence; Swine; Thyroglobulin; | 2012 |
Postpartum recurrence of Graves' hyperthyroidism can be prevented by the continuation of antithyroid drugs during pregnancy.
Topics: Adult; Antithyroid Agents; Female; Follow-Up Studies; Graves Disease; Humans; Pregnancy; Prenatal Ca | 2002 |
Relapses of hyperthyroidism in patients treated with radioiodine for nodular toxic goiter: relation to thyroid autoimmunity.
Topics: Aged; Aged, 80 and over; Autoantibodies; Female; Goiter, Nodular; Humans; Hyperthyroidism; Iodine Ra | 2003 |
ENTERIC COATED THYROID AS A CAUSE OF RELAPSE IN MYXEDEMA.
Topics: Myxedema; Recurrence; Tablets; Tablets, Enteric-Coated; Thyroid Hormones; Triiodothyronine | 1964 |
Long-term validity of biological markers of psychopathy and criminal recidivism: follow-up 6-8 years after forensic psychiatric investigation.
Topics: Adolescent; Adult; Aggression; Antisocial Personality Disorder; Biomarkers; Blood Platelets; Crime; | 2004 |
Recurrent gestational thyrotoxicosis presenting as recurrent hyperemesis gravidarum--report of two cases.
Topics: Abortion, Spontaneous; Adult; Antithyroid Agents; Carbimazole; Female; Gestational Age; Heart Rate, | 2004 |
Relationship between the sonographic appearance of the thyroid and the clinical course and autoimmune activity of Graves' disease.
Topics: Adult; Aged; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Pro | 2005 |
The significance of thyroid blood flow at the inferior thyroid artery as a predictor for early Graves' disease relapse.
Topics: Adolescent; Adult; Aged; Arteries; Autoantibodies; Case-Control Studies; Female; Graves Disease; Hum | 2005 |
Recurrent painful unilateral gynaecomastia-interactions between hyperthyroidism and hypogonadism.
Topics: Aged, 80 and over; Androgens; Antithyroid Agents; Carbimazole; Estrogens; Follicle Stimulating Hormo | 2006 |
The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
Topics: Adult; Antithyroid Agents; Autoantibodies; Diagnosis, Differential; Female; Graves Disease; Humans; | 2007 |
Recurrent silent thyroiditis: a report of four patients and review of the literature.
Topics: Adult; Female; Humans; Male; Recurrence; Thyroiditis; Thyroxine; Triiodothyronine | 2007 |
The significance of triiodothyronine in the evaluation of thyroid function after treatment for hyperthyroidism.
Topics: Adult; Aged; Antithyroid Agents; Female; Goiter, Nodular; Graves Disease; Humans; Hyperthyroidism; M | 1980 |
[Clinical significance of elevated serum triiodothyronine to thyroxine ratios in patients with Graves' disease treated with antithyroid drugs].
Topics: Adolescent; Adult; Antithyroid Agents; Child; Female; Graves Disease; Humans; Male; Methimazole; Mid | 1983 |
[Determination of the optimal L-thyroxine dosage for treating nontoxic goiter].
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Goiter; Humans; Male; Middle Aged | 1983 |
Long-standing recurrent paroxysmal supraventricular tachycardia disappearing after cystic degeneration of an episodically hypersecreting toxic adenoma of the thyroid.
Topics: Adenoma; Adult; Female; Humans; Necrosis; Recurrence; Tachycardia, Paroxysmal; Thyroid Neoplasms; Th | 1984 |
Ratio of serum triiodothyronine to thyroxine and the prognosis of triiodothyronine-predominant Graves' disease.
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Male; Methimazole; Prognosis; Propylthiouracil; R | 1984 |
Thyroxine replacement requirements in hypothyroid patients receiving phenytoin.
Topics: Adult; Drug Administration Schedule; Female; Humans; Hypothyroidism; Phenytoin; Recurrence; Thyrotro | 1983 |
Outcome of patients with Graves' disease after long-term medical treatment guided by triiodothyronine (T3) suppression test.
Topics: Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Graves Disease; Humans; Male; Middle Aged | 1983 |
[The effectiveness of recurrence prophylaxis four to five years after struma surgery].
Topics: Goiter, Endemic; Humans; Postoperative Complications; Recurrence; Thyrotropin; Thyrotropin-Releasing | 1980 |
Thionamide therapy in Graves' disease: relation of relapse rate to duration of therapy.
Topics: Adolescent; Adult; Child; Female; Follow-Up Studies; Graves Disease; Humans; Male; Methimazole; Prop | 1980 |
Recurrence and heterogeneity in painless thyrotoxic lymphocytic thyroiditis. Report of five cases.
Topics: Adult; Female; Humans; Hyperthyroidism; Iodides; Iodine Radioisotopes; Pain; Recurrence; Remission, | 1982 |
Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.
Topics: Adult; Aged; Amiodarone; Atrial Flutter; Benzofurans; Electrocardiography; Heart Ventricles; Humans; | 1982 |
Nontoxic goitre. II. A study of the pituitary-thyroid axis in 14 recurrent cases.
Topics: Adult; Female; Goiter; Humans; Male; Middle Aged; Postoperative Period; Recurrence; Thyrotropin; Thy | 1982 |
Thyroid hormone resistance in a 35-year old man with recurrent goitre.
Topics: Adult; Body Temperature; Goiter; Heart Rate; Humans; Male; Metabolic Clearance Rate; Pituitary Gland | 1982 |
The hypothalamic-pituitary-thyroid axis in patients maintained on lithium prophylaxis for years: high triiodothyronine serum concentrations are correlated to the prophylactic efficacy.
Topics: Adult; Aged; Aged, 80 and over; Bipolar Disorder; Depressive Disorder; Female; Humans; Hypothalamo-H | 1995 |
Simple and reliable method for predicting the remission of Graves' disease: revised triiodothyronine-suppression test, indexed by serum thyroxine.
Topics: Adult; Case-Control Studies; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Prognos | 1995 |
[Hyperthyroidism at elevated thyreostimulin. A case with pituitary resistance to thyroid hormones].
Topics: Adult; Drug Therapy, Combination; Humans; Hyperthyroidism; Male; Pituitary Diseases; Propranolol; Re | 1994 |
Changes in triiodothyronine mark severe pain syndrome: a case report.
Topics: Biomarkers; Humans; Jaw; Male; Middle Aged; Pain; Recurrence; Severity of Illness Index; Syndrome; T | 1994 |
[The thyroid gland in patients with sarcoidosis].
Topics: Adult; Female; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Recurrence; Sarcoidosis, P | 1994 |
Serum soluble CD8 concentration is an indicator of disease activity in patients with Graves' disease.
Topics: Adult; Biomarkers; CD4 Antigens; CD8 Antigens; Female; Graves Disease; Humans; Immunity, Cellular; L | 1994 |
Age-related therapeutic response to antithyroid drug in patients with hyperthyroid Graves' disease.
Topics: Adolescent; Adult; Aged; Aging; Child; Female; Graves Disease; Humans; Lymphocyte Subsets; Male; Met | 1994 |
[Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Topics: Adult; Aged; Antithyroid Agents; Autoantibodies; Child; Female; Graves Disease; Humans; Iodine Radio | 1998 |
Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosphamide and ifosfamide).
Topics: Adult; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexameth | 1999 |
Thyroid hormone levels and recurrence of major depression.
Topics: Adult; Ambulatory Care; Depressive Disorder; Female; Humans; Male; Recurrence; Survival Analysis; Th | 2000 |
Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Autoantibodies; Carbimazole; Chi-Square Distribution; F | 2001 |
Side-effects of iodized oil administration in patients with simple goiter.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Goiter; Humans; Hyperthyroidism; Hypothyroidism; | 2001 |
Evaluation of recurrence in 36 subacute thyroiditis patients managed with prednisolone.
Topics: Adult; Aged; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Female; Follow-Up Studies; Hu | 2001 |
[Graves' disease. Clinical features and treatment results].
Topics: Antithyroid Agents; Disease-Free Survival; Female; Graves Disease; Humans; Iodine Radioisotopes; Mal | 2001 |
Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease.
Topics: Adult; Aged; Animals; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Immunoglob | 2002 |
Hormonal pattern of relapse in hyperthyroidism.
Topics: Carbimazole; Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Radioimmunoassay; Recurrenc | 1975 |
[The effectiveness ot thyroid-hormone therapy following goiter-resection].
Topics: Adolescent; Adult; Aged; Child; Female; Follow-Up Studies; Goiter; Humans; Male; Middle Aged; Palpat | 1975 |
[Management of patients with thyrotoxicosis of childbearing age (author's transl)].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Antithyroid Agents; Female; Graves Diseas | 1977 |
Long term antithyroid drug therapy for intractable cases of Graves' disease.
Topics: Adult; Antithyroid Agents; Female; Graves Disease; Humans; Male; Middle Aged; Recurrence; Thyroxine; | 1978 |
[Goiter. Diagnosis and therapy in practice].
Topics: Diagnosis, Differential; Goiter; Humans; Long-Term Care; Recurrence; Thyroid Diseases; Thyroxine; Tr | 1979 |
Recurrent transient thyrotoxicosis with painless thyroiditis--a case report.
Topics: Adult; Autoantibodies; Female; Humans; Hyperthyroidism; Recurrence; Thyroid Gland; Thyroiditis; Thyr | 1979 |
Iodine organification defect following treatment of thyrotoxicosis with antithyroid drugs.
Topics: Carbimazole; Female; Humans; Hyperthyroidism; Iodine; Iodine Radioisotopes; Middle Aged; Perchlorate | 1975 |
Thyroid function after subtotal resecti-n for hyper-thyroidism: a prospective study.
Topics: Adult; Aged; Female; Humans; Hyperthyroidism; Male; Middle Aged; Prospective Studies; Recurrence; Th | 1978 |
[Clinical and hormonal evaluation of recurrence of goiter after thyroidectomy].
Topics: Adolescent; Adult; Age Factors; Female; Goiter; Humans; Male; Middle Aged; Parity; Recurrence; Sex F | 1979 |
[Drug follow-up therapy after resection of hyperthyroid struma].
Topics: Drug Therapy, Combination; Female; Goiter; Humans; Male; Recurrence; Thyroxine; Time Factors; Triiod | 1979 |
Transient recurrence of hyperthyroidism after delivery in Graves' disease.
Topics: Adult; Autoantibodies; Female; Graves Disease; Humans; Hyperthyroidism; Immunoglobulins; Microsomes; | 1977 |
[Therapy of hyperthyroidism, compiled according to the recommendations of the section on thyroid gland of the German Endocrinological Society. 2. Control of therapy, therapy of endocrine ophthalmopathies, therapy during pregnancy and in childhood].
Topics: Adrenal Cortex Hormones; Child; Female; Graves Disease; Humans; Hyperthyroidism; Pregnancy; Prognosi | 1977 |
[Long term follow-up after thyroidectomy].
Topics: Follow-Up Studies; Graves Disease; Humans; Hyperthyroidism; Recurrence; Thyroid Neoplasms; Thyroidec | 1978 |
Recurrent acute suppurative thyroiditis.
Topics: Acute Disease; Bacterial Infections; Bacteroides Infections; Child; Humans; Male; Peptococcus; Pepto | 1978 |
[Recurrent goiter with and without prevention].
Topics: Goiter; Humans; Recurrence; Thyrotropin; Thyroxine; Triiodothyronine | 1978 |
[Approach to a differentiated recurrence prevention following struma surgery].
Topics: Adenoma; Goiter; Humans; Pituitary Function Tests; Recurrence; Thyroid Function Tests; Thyroid Hormo | 1978 |
[The hypophyseal TSH reserve in surgical patients with bland goiter and recurrent goiter].
Topics: Adult; Aged; Female; Goiter; Humans; Hypothyroidism; Male; Middle Aged; Recurrence; Thyrotropin; Thy | 1976 |
[Single weekly doses of 1 mg 1-thyroxine for the treatment of mild goiter and for the prevention of recurrence after goiter surgery].
Topics: Goiter; Humans; Iodine Radioisotopes; Organ Size; Radiography; Radionuclide Imaging; Recurrence; Thy | 1976 |
Long-term observation of thyroid function after surgical treatment of thyrotoxicosis.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Goiter, Nodular; Humans; Hyperthyroidism; Male; | 1977 |
[The course of diffuse hyperthyroidism in Basedow disease].
Topics: Adult; Antithyroid Agents; Combined Modality Therapy; Female; Follow-Up Studies; Graves Disease; Hum | 1990 |
[Evaluation of a logistic regression model in predicting the prognosis of Graves' disease treated by antithyroid drugs].
Topics: Adolescent; Adult; Child; Female; Follow-Up Studies; Graves Disease; Humans; Logistic Models; Male; | 1991 |
A follow-up study of 85 patients with Graves' disease in remission who developed undetectable serum thyroid-stimulating hormone concentrations using sensitive TSH assays.
Topics: Adult; Follow-Up Studies; Graves Disease; Humans; Methimazole; Middle Aged; Recurrence; Remission In | 1991 |
Studies on the T3 suppression test with reference to the thyroidal 123I uptake in Graves' disease: comparison of 24-hour and 3-hour uptake.
Topics: Female; Graves Disease; Humans; Iodine Radioisotopes; Male; Methimazole; Predictive Value of Tests; | 1990 |
[Familial nonneoplastic inappropriate thyrotropin secretion].
Topics: Carcinoma; Diagnosis, Differential; Drug Therapy, Combination; Female; Goiter; Humans; Middle Aged; | 1990 |
[Observation of the outcome of 112 cases with Graves' disease treated by short-term antithyroid drug therapy for one year].
Topics: Adolescent; Adult; Child; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Prospectiv | 1990 |
Evaluation of TSH-receptor antibodies as prognostic markers after cessation of antithyroid drug treatment in patients with Graves' disease.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Immunoglobulin G; Immun | 1988 |
TSH response to TRH in depression with and without panic attacks.
Topics: Adult; Depressive Disorder; Fear; Female; Humans; Hydrocortisone; Male; Panic; Recurrence; Sex Facto | 1989 |
The prognostic value of TSH receptor binding and thyroid stimulating antibodies following antithyroid drug treatment of Graves' disease.
Topics: Adult; Carbimazole; Drug Therapy, Combination; Female; Graves Disease; Humans; Immunoglobulin G; Imm | 1989 |
Prediction of the course of Graves' disease after medical antithyroid treatment.
Topics: Adolescent; Adult; Aged; Antibodies; Female; Graves Disease; Humans; Immunoglobulin G; Immunoglobuli | 1985 |
Twenty-four-hour serum levels of T4 and T3 in relation to decreased TSH serum levels and decreased TSH response to TRH in affective disorders.
Topics: Adult; Body Weight; Depressive Disorder; Female; Humans; Male; Middle Aged; Receptors, Cell Surface; | 1986 |
Serum thyroglobulin concentration in nontoxic goiter and response to surgery with special reference to risk of goiter relapse.
Topics: Adult; Antibodies; Female; Goiter; Humans; Male; Microsomes; Middle Aged; Recurrence; Risk; Thyroglo | 1986 |
Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Topics: Adult; Autoantibodies; DNA; Female; Graves Disease; HLA-DR Antigens; Humans; Lymphocytes; Male; Meth | 1988 |
Problems with asthma following treatment of thyrotoxicosis.
Topics: Adult; Asthma; Carbimazole; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Middle Aged; Re | 1988 |
Recurrence of subacute thyroiditis over 10 years after the first attack in three cases.
Topics: Adult; Antibodies, Viral; Female; HLA Antigens; Humans; Middle Aged; Prednisolone; Recurrence; Thyro | 1988 |
Thyroid amyloidosis with recurrent subacute thyroiditis-like syndrome.
Topics: Adult; Amyloidosis; Crohn Disease; Female; Humans; Male; Middle Aged; Recurrence; Syndrome; Thyroid | 1988 |
Hypothalamic hypothyroidism with end-organ resistance--further personal observations.
Topics: Adrenal Glands; Humans; Hypothalamus; Hypothyroidism; Recurrence; Seasons; Thyroid Gland; Triiodothy | 1986 |
Total and free triiodothyronine and thyroxine levels in thyroid storm and recurrent hyperthydroidism.
Topics: Adolescent; Child; Female; Graves Disease; Humans; Hyperthyroidism; Iodine; Postoperative Complicati | 1973 |
Thyroid disease and some complications.
Topics: Antithyroid Agents; Asphyxia; Goiter; Goiter, Nodular; Hemorrhage; Humans; Hypothyroidism; Recurrenc | 1973 |
Serum thyrotrophin and circulating thyroglobulin antibodies in subjects with non-toxic goitre and in euthyroid subjects who had undergone subtotal thyroidectomy or radioiodine therapy.
Topics: Adult; Antibodies; Cholesterol; Female; Finland; Follow-Up Studies; Goiter; Hemagglutination Tests; | 1973 |
[Frequency of recurrence following treatment of hyperthyroidism with methimazole and suppressibility of the thyroid gland (author's transl)].
Topics: Adult; Animals; Antibodies; Female; Humans; Hyperthyroidism; Iodine Radioisotopes; Long-Acting Thyro | 1973 |
[Therapeutic suppression of TSH secretion in bland struma, recurring struma and recurrence prevention following struma resection].
Topics: Depression, Chemical; Goiter; Humans; Recurrence; Thyroidectomy; Thyrotropin; Thyroxine; Triiodothyr | 1974 |
[Indications and results of endemic goiter drug therapy with synthetic thyroid hormones].
Topics: Drug Combinations; Female; Goiter; Goiter, Nodular; Humans; Iodine Radioisotopes; Male; Postoperativ | 1973 |
[Goiter recurrence prophylaxis in an endemic goiter region].
Topics: Follow-Up Studies; Goiter, Endemic; Humans; Iodine; Iodine Radioisotopes; Postoperative Care; Recurr | 1973 |
Recurrent hyperthyroidism presenting as triiodothyronine toxicosis.
Topics: Adenoma; Adult; Aged; Female; Graves Disease; Humans; Hyperthyroidism; Male; Middle Aged; Radioimmun | 1972 |
[Triiodothyronine-thyrotoxicosis].
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Protein Binding; Recurrence; Thyroglobulin | 1972 |
[Treatment of nontoxic goiter with synthetic thyroid hormones].
Topics: Drug Combinations; Female; Follow-Up Studies; Goiter; Humans; Male; Recurrence; Thyroid Gland; Thyro | 1973 |
Congenital hypothyroidism and prolonged neonatal hyperbilirubinemia.
Topics: Congenital Hypothyroidism; Female; Humans; Hypothyroidism; Infant, Newborn; Jaundice, Neonatal; Recu | 1967 |
T3 toxicosis in childhood: hyperthyroidism due to isolated hypersecretion of triiodothyronine.
Topics: Child; Chromatography; Female; Humans; Hyperthyroidism; Iodine Radioisotopes; Propylthiouracil; Prot | 1972 |
[Prevention of recurrence by means of a thyroxine-triiodothyronine combination following strumectomy].
Topics: Goiter; Humans; Hyperthyroidism; Postoperative Care; Radionuclide Imaging; Recurrence; Secondary Pre | 1971 |
Recurrent thyrotoxicosis after subtotal thyroidectomy.
Topics: Autoantibodies; Gastric Mucosa; Graves Disease; Humans; Immunoglobulin G; Iodine Radioisotopes; Long | 1971 |
[Conservative treatment of euthyroid and recurrent goiter using a thyroid hormone drug].
Topics: Adolescent; Adult; Child; Chronic Disease; Female; Germany, East; Germany, West; Goiter; Goiter, End | 1970 |